Literature DB >> 12809176

Effects of a 3-week integrated body weight reduction program on leptin levels and body composition in severe obese subjects.

A Sartorio1, F Agosti, M Resnik, C L Lafortuna.   

Abstract

The effects of short-term (3 weeks) integrated body weight reduction (BWR) program (including energy-restricted diet, aerobic and strength exercise (5 days/week), nutritional education and psychological counseling) on plasma leptin levels and body composition were investigated in 54 morbidly obese patients (38 females/16 males; mean BMI +/- SE: 41.8 +/- 0.1 kg/m2, range 35-58 kg/m2; mean age: 29.8 +/- 1.0 yr, age range: 18-46 yr). The BWR program induced a significant (p < 0.001) weight loss (BMI reduction: -4.8%) and a significant modification in body composition, consisting in a fat mass (FM) decrease (-7.0 +/- 0.4%, p < 0.001) with a concomitant fat-free (FFM) mass increase (1.8 +/- 0.3%, p < 0.001). On average, plasma leptin levels decreased significantly both in males (from 19.4 +/- 2.6 ng/ml to 11.6 +/- 1.3 ng/ml, p < 0.001) and in females (from 41.1 +/- 3.6 ng/ml to 29.9 +/- 3.0 ng/ml, p < 0.001). Both before and after weight loss, leptin levels were positively correlated (p < 0.001) with BMI and percent fat mass (FM) values. Weight changes after the BWR program were negatively correlated with baseline leptin concentrations both in absolute terms and expressed per unit FM. In conclusion, a short-term diet plus aerobic/strength training effectively induces body composition changes and reduces plasma leptin levels. Body FM reduction appears to be not the unique determinant of leptin levels regulation and the degree of leptin over-expression may negatively affect weight loss in morbidly obese patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12809176     DOI: 10.1007/BF03345165

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Delayed effects of exercise on the plasma leptin concentration.

Authors:  D A Essig; N L Alderson; M A Ferguson; W P Bartoli; J L Durstine
Journal:  Metabolism       Date:  2000-03       Impact factor: 8.694

2.  Changes in motor control and muscle performance after a short-term body mass reduction program in obese subjects.

Authors:  A Sartorio; C L Lafortuna; G Conte; G Faglia; M V Narici
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

Review 3.  Physical activity in the prevention of obesity: current evidence and research issues.

Authors:  L DiPietro
Journal:  Med Sci Sports Exerc       Date:  1999-11       Impact factor: 5.411

4.  Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution.

Authors:  C T Montague; J B Prins; L Sanders; J E Digby; S O'Rahilly
Journal:  Diabetes       Date:  1997-03       Impact factor: 9.461

5.  Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women.

Authors:  G R Dubuc; S D Phinney; J S Stern; P J Havel
Journal:  Metabolism       Date:  1998-04       Impact factor: 8.694

6.  The effect of exercise training on leptin levels in obese males.

Authors:  W J Pasman; M S Westerterp-Plantenga; W H Saris
Journal:  Am J Physiol       Date:  1998-02

7.  Influence of diet and exercise on skeletal muscle and visceral adipose tissue in men.

Authors:  R Ross; J Rissanen; H Pedwell; J Clifford; P Shragge
Journal:  J Appl Physiol (1985)       Date:  1996-12

8.  Leptin serum concentrations predict the responsiveness of obese children and adolescents to weight excess reduction program.

Authors:  G Di Stefano; V Bini; F Papi; F Celi; G Contessa; M G Berioli; M L Bacosi; A Falorni
Journal:  Int J Obes Relat Metab Disord       Date:  2000-12

9.  Effect of exercise training on serum leptin levels in type 2 diabetic patients.

Authors:  T Ishii; T Yamakita; K Yamagami; T Yamamoto; M Miyamoto; K Kawasaki; M Hosoi; K Yoshioka; T Sato; S Tanaka; S Fujii
Journal:  Metabolism       Date:  2001-10       Impact factor: 8.694

10.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

View more
  10 in total

1.  Psychological wellbeing and biochemical modulation in response to weight loss in obese type 2 diabetes patients.

Authors:  Al-Jiffri Osama; Abd El-Kader Shehab
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

2.  Effect of a 3-week body mass reduction program on body composition, muscle function and motor performance in pubertal obese boys and girls.

Authors:  N A Maffiuletti; A De Col; F Agosti; S Ottolini; D Moro; M Genchi; M Massarini; C L Lafortuna; A Sartorio
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

3.  Changes in the Oswestry Disability Index after a 3-Week In-Patient Multidisciplinary Body Weight Reduction Program in Adults with Obesity.

Authors:  Munkh-Erdene Bayartai; Hannu Luomajoki; Roberta De Micheli; Gabriella Tringali; Nicoletta Marazzi; Alessandro Sartorio
Journal:  J Clin Med       Date:  2022-06-02       Impact factor: 4.964

4.  Changes in weight loss, body composition and cardiovascular disease risk after altering macronutrient distributions during a regular exercise program in obese women.

Authors:  Chad M Kerksick; Jennifer Wismann-Bunn; Donovan Fogt; Ashli R Thomas; Lem Taylor; Bill I Campbell; Colin D Wilborn; Travis Harvey; Mike D Roberts; Paul La Bounty; Melyn Galbreath; Brandon Marcello; Christopher J Rasmussen; Richard B Kreider
Journal:  Nutr J       Date:  2010-11-22       Impact factor: 3.271

Review 5.  Effects of lifestyle interventions that include a physical activity component in class II and III obese individuals: a systematic review and meta-analysis.

Authors:  Aurélie Baillot; Ahmed J Romain; Katherine Boisvert-Vigneault; Mélisa Audet; Jean Patrice Baillargeon; Isabelle J Dionne; Louis Valiquette; Claire Nour Abou Chakra; Antoine Avignon; Marie-France Langlois
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

6.  Comparison of the effect of rapeseed oil or amaranth seed oil supplementation on weight loss, body composition, and changes in the metabolic profile of obese patients following 3-week body mass reduction program: a randomized clinical trial.

Authors:  Małgorzata Moszak; Agnieszka Zawada; Aldona Juchacz; Marian Grzymisławski; Paweł Bogdański
Journal:  Lipids Health Dis       Date:  2020-06-20       Impact factor: 3.876

7.  Effects of a popular exercise and weight loss program on weight loss, body composition, energy expenditure and health in obese women.

Authors:  Chad Kerksick; Ashli Thomas; Bill Campbell; Lem Taylor; Colin Wilborn; Brandon Marcello; Mike Roberts; Emily Pfau; Megan Grimstvedt; Jasmine Opusunju; Teresa Magrans-Courtney; Christopher Rasmussen; Ron Wilson; Richard B Kreider
Journal:  Nutr Metab (Lond)       Date:  2009-05-14       Impact factor: 4.169

8.  An energy-reduced dietary pattern, including moderate protein and increased nonfat dairy intake combined with walking promotes beneficial body composition and metabolic changes in women with excess adiposity: a randomized comparative trial.

Authors:  Julie D Shlisky; Carrie M Durward; Melissa K Zack; Carolyn K Gugger; Jessica K Campbell; Sharon M Nickols-Richardson
Journal:  Food Sci Nutr       Date:  2015-04-13       Impact factor: 2.863

9.  Regular exercise modulates obesity factors and body composition in sturdy men.

Authors:  Il-Gyu Ko; Pil-Byung Choi
Journal:  J Exerc Rehabil       Date:  2013-04-25

10.  A 3-Week Multidisciplinary Body Weight Reduction Program Improves Body Composition and Lower Limb Power Output in 3,778 Severely Obese Children and Adolescents.

Authors:  Stefano Lazzer; Giulia Bravo; Gabriella Tringali; Roberta De Micheli; Alessandra De Col; Alessandro Sartorio
Journal:  Front Physiol       Date:  2020-05-28       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.